US Predictive Genetic Testing and Consumer Wellness Genomics Market

ID: MRFR/LS/18153-HCR
100 Pages
Vikita Thakur
Last Updated: April 06, 2026
US Genomics Market Research Report By Application (Drug Discovery, Clinical Diagnostics, Personalized Medicine, Genetic Testing), By Technology (Sequencing, Microarray, PCR, CRISPR) and By End Use (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies) - Growth & Industry Forecast 2025 To 2035.
US Predictive Genetic Testing and Consumer Wellness Genomics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)8.9%
2024 Market Size$ 1,302.01 Million
2025 Market Size$ 1,417.89 Million
2035 Market Size$ 3,327.05 Million
Key Players
23andMe
Ancestry
MyHeritage
Invitae
Color Genomics
Gene by Gene
Trends
  • Increased Consumer Adoption
  • Technological Advancements
  • Regulatory Developments
Opportunities
  • Rising Health Awareness
  • Integration of AI and Machine Learning
  • Expansion of Direct-to-Consumer Testing
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Test Type (USD Million)
      1. 4.1.1 Predictive Testing
      2. 4.1.2 Consumer Genomics
      3. 4.1.3 Wellness Genomics
    2. 4.2 Construction, BY Application (USD Million)
      1. 4.2.1 Breast & Ovarian Cancer
      2. 4.2.2 Cardiovascular Screening
      3. 4.2.3 Diabetic Screening & Monitoring
      4. 4.2.4 Colon Cancer
      5. 4.2.5 Parkinsonism/Alzheimer’s Disease
      6. 4.2.6 Urologic Screening/Prostate Cancer Screening
      7. 4.2.7 Orthopedic & Musculoskeletal
    3. 4.3 Construction, BY Setting Type (USD Million)
      1. 4.3.1 Proteomic Testing
      2. 4.3.2 Metabolic Testing
      3. 4.3.3 Genomic Testing
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 23andMe (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Ancestry (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 MyHeritage (IL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Invitae (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Color Genomics (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Gene by Gene (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Fulgent Genetics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 GenoPalate (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TEST TYPE
    3. 6.3 US MARKET ANALYSIS BY APPLICATION
    4. 6.4 US MARKET ANALYSIS BY SETTING TYPE
    5. 6.5 KEY BUYING CRITERIA OF CONSTRUCTION
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF CONSTRUCTION
    8. 6.8 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 SUPPLY / VALUE CHAIN: CONSTRUCTION
    11. 6.11 CONSTRUCTION, BY TEST TYPE, 2024 (% SHARE)
    12. 6.12 CONSTRUCTION, BY TEST TYPE, 2024 TO 2035 (USD Million)
    13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 CONSTRUCTION, BY SETTING TYPE, 2024 (% SHARE)
    16. 6.16 CONSTRUCTION, BY SETTING TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY SETTING TYPE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Predictive Genetic Testing and Consumer Wellness Genomics Market Segmentation

US Predictive Genetic Testing and Consumer Wellness Genomics Market By Test Type (USD Million, 2025-2035)

  • Predictive Testing
  • Consumer Genomics
  • Wellness Genomics

US Predictive Genetic Testing and Consumer Wellness Genomics Market By Application (USD Million, 2025-2035)

  • Breast & Ovarian Cancer
  • Cardiovascular Screening
  • Diabetic Screening & Monitoring
  • Colon Cancer
  • Parkinsonism/Alzheimer’s Disease
  • Urologic Screening/Prostate Cancer Screening
  • Orthopedic & Musculoskeletal

US Predictive Genetic Testing and Consumer Wellness Genomics Market By Setting Type (USD Million, 2025-2035)

  • Proteomic Testing
  • Metabolic Testing
  • Genomic Testing

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.